Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 10, 2022
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies
Susana M Campos, Suzanne Berlin, Carolyn N Krasner, et al.
Gynecologic Oncology
|
July 2, 2024
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis
Jaclyn A Wall, Rachel A Pozzar, Andrea C Enzinger, et al.
Gynecologic Oncology
|
May 29, 2020
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
Julian C Schink, Virginia Filiaci, Helen Q Huang, et al.
Obstetrics and Gynecology
|
February 19, 2026
Tracking the Cesarean Delivery-Postmolar Gestational Trophoblastic Neoplasia Link
Gabriela Paiva, Antônio Braga, Solange Artimos de Oliveira, et al.
Ceska Gynekologie
|
January 23, 2026
Atypical placental site nodule detected via hysteroscopy - first case report from Brazil
Antônio Braga, Gabriela Paiva, Lilian Padron, et al.
International Journal of Clinical Oncology
|
November 7, 2022
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
Susana Campos, Ursula Matulonis, Suzanne Berlin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 8, 2020
Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America
Izildinha Maestá, Marjory de Freitas Segalla Moreira, Jorge Rezende-Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2021
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
Joyce F Liu, Niya Xiong, Susana M Campos, et al.
JAMA Oncology
|
October 11, 2019
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Joyce F Liu, Christina Herold, Kathryn P Gray, et al.
Gynecologic Oncology
|
December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R Conner, Emily Meserve, Ellen Pizer, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
February 10, 2022
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies
Susana M Campos, Suzanne Berlin, Carolyn N Krasner, et al.
Gynecologic Oncology
|
July 2, 2024
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis
Jaclyn A Wall, Rachel A Pozzar, Andrea C Enzinger, et al.
Gynecologic Oncology
|
May 29, 2020
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
Julian C Schink, Virginia Filiaci, Helen Q Huang, et al.
Obstetrics and Gynecology
|
February 19, 2026
Tracking the Cesarean Delivery-Postmolar Gestational Trophoblastic Neoplasia Link
Gabriela Paiva, Antônio Braga, Solange Artimos de Oliveira, et al.
Ceska Gynekologie
|
January 23, 2026
Atypical placental site nodule detected via hysteroscopy - first case report from Brazil
Antônio Braga, Gabriela Paiva, Lilian Padron, et al.
International Journal of Clinical Oncology
|
November 7, 2022
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
Susana Campos, Ursula Matulonis, Suzanne Berlin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 8, 2020
Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America
Izildinha Maestá, Marjory de Freitas Segalla Moreira, Jorge Rezende-Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2021
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
Joyce F Liu, Niya Xiong, Susana M Campos, et al.
JAMA Oncology
|
October 11, 2019
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Joyce F Liu, Christina Herold, Kathryn P Gray, et al.
Gynecologic Oncology
|
December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R Conner, Emily Meserve, Ellen Pizer, et al.
Page
of 7